학술논문

Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients
Document Type
article
Source
Türk Kardiyoloji Derneği Arşivi, Vol 47, Iss 7, Pp 564-571 (2019)
Subject
atrial fibrillation
electrical cardioversion
galectin-3
remodeling.
Medicine
Internal medicine
RC31-1245
Diseases of the circulatory (Cardiovascular) system
RC666-701
Language
English
Turkish
ISSN
1016-5169
Abstract
Objective: Atrial structural remodeling has been suggested to contribute to atrial fibrillation (AF) recurrence following direct-current cardioversion (DCCV). The role of several inflammatory and extracellular matrix turnover markers in AF recurrence following DCCV has been investigated. However, data on the impact of galectin-3, which is known to play a role in various fibrotic conditions, including cardiac fibrosis are lacking. The aim of this study was to demonstrate the predictive role of serum galectin-3 levels in AF recurrence following successful DCCV. Methods: A total of 90 persistent AF patients who were sche-duled for DCCV were prospectively enrolled. Serum samples were assayed to determine pre-DCCV galectin-3 levels using the enzyme-linked immunosorbent assay method. Patients were followed up for 3 months for AF recurrence. Results: Of 90 persistent AF patients (mean age: 55.33+-7.94 years; 53.33% male) who underwent successful DCCV, 28 (31.11%) experienced early AF recurrence within 3 months. Patients with AF recurrence had a greater left atrial volume index (LAVI) (33.35+- 2.45 mL/m2 vs. 29.21+-3.08 mL/m2; p